| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/31/2011 | EP2361245A1 Hybrid -ionone and curcumin molecules as anticancer agents |
| 08/31/2011 | EP2361243A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 08/31/2011 | EP2361242A1 Oxidase inhibitors and their use |
| 08/31/2011 | EP2361092A1 Health care |
| 08/31/2011 | EP2361090A1 Compositions for treating centrally mediated nausea and vomiting |
| 08/31/2011 | EP2361089A1 Compositions and methods for the treatment of altered -synuclein function |
| 08/31/2011 | EP2361088A2 Method of inducing cleavage of amyloid precursor protein to form a novel fragment |
| 08/31/2011 | EP2361087A1 Anti-inflammatory compounds and compositions thereof |
| 08/31/2011 | EP2361086A1 Treatment of oncological diseases |
| 08/31/2011 | EP2361085A2 Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer |
| 08/31/2011 | EP2361084A2 Electrostatically charged multi-acting nasal application, product, and method |
| 08/31/2011 | EP2361083A1 Composition for treatment of epithelial tissue |
| 08/31/2011 | EP2361082A1 Coated tablets with a remaining degradation surface over the time |
| 08/31/2011 | EP2361055A1 Improved bolus |
| 08/31/2011 | EP2361053A1 Improvements in bolus devices for the delivery of active agents to animals |
| 08/31/2011 | EP2271638B1 Modulators of dopamine neurotransmission |
| 08/31/2011 | EP2257553B1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
| 08/31/2011 | EP2257545B1 Pyrrolidinyl derivatives and uses thereof |
| 08/31/2011 | EP2250172B1 Pyrrolopyrazine kinase inhibitors |
| 08/31/2011 | EP2247592B1 Pyrrolopyrazine kinase inhibitors |
| 08/31/2011 | EP2245033B1 Pyrrolopyrazine kinase inhibitors |
| 08/31/2011 | EP2231676B1 (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo-[a,d]-cyclohepten-5-ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis |
| 08/31/2011 | EP2231655B1 4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl)benzenesulfonamide derivatives and related compounds as modulators of ion channels for the treatment of pain |
| 08/31/2011 | EP2215054B1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 08/31/2011 | EP2214659B1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 08/31/2011 | EP2205594B1 1,3,5-trisubstituted triazole derivative |
| 08/31/2011 | EP2203426B1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 08/31/2011 | EP2201000B1 Novel imidazole derivatives |
| 08/31/2011 | EP2193204B1 Compositions comprising lipophosphoramides and their uses in gene therapy |
| 08/31/2011 | EP2183027B1 Organic compounds |
| 08/31/2011 | EP2173748B1 Indolyl pyrrolidines for the treatment of cancer |
| 08/31/2011 | EP2173723B1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 08/31/2011 | EP2170891B1 Pyrazolopyrimidinone kinase inhibitor |
| 08/31/2011 | EP2121697B1 Compounds for the treatment of hepatitis c |
| 08/31/2011 | EP2121683B1 2-piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
| 08/31/2011 | EP2117564B1 Use of chitosans to increase nail growth rate |
| 08/31/2011 | EP2117553B1 Compositions for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory track |
| 08/31/2011 | EP2078007B1 Ikk-beta serine-threonine protein kinase inhibitors |
| 08/31/2011 | EP2073810B1 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer, autoimmune disorders and hiv infection |
| 08/31/2011 | EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 08/31/2011 | EP2029110B1 Process for preparing spray dried formulations of tmc125 |
| 08/31/2011 | EP2020999B1 Compositions comprising alpha-ketoglutarate and their use for modulating muscle performance |
| 08/31/2011 | EP2018395B1 Short interference ribonucleic acids for treating allegic diseases |
| 08/31/2011 | EP2006287B1 Compound with antimalarial activity and antimalarial drug containing the same as active ingredient |
| 08/31/2011 | EP1984345B1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 08/31/2011 | EP1828222B9 Process for the preparation of drospirenone |
| 08/31/2011 | EP1781291B9 Opioids for the treatment of the restlessness of the lower limbs |
| 08/31/2011 | EP1678139B1 Solid-state montelukast |
| 08/31/2011 | EP1660037B1 Aripiprazole injectable suspension |
| 08/31/2011 | EP1634589B9 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 08/31/2011 | EP1568688B1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient |
| 08/31/2011 | EP1523325B1 Methods and compositions for treating polycystic ovary syndrome |
| 08/31/2011 | EP1523305B1 Device and patch for controlling the release of vanillin |
| 08/31/2011 | EP1521754B1 Viral inhibitors |
| 08/31/2011 | EP1509492B1 Short-acting sedative hypnotic agents for anesthesia and sedation |
| 08/31/2011 | EP1506000B9 Heterocyclicsulfonamide hepatitis c virus inhibitors |
| 08/31/2011 | EP1493441B1 Therapeutic agent for food competence disorder in stomach |
| 08/31/2011 | EP1481671B1 Compositions and foods for improving lipid metabolism |
| 08/31/2011 | EP1467712B2 Method of producing a bilayer pharmaceutical tablet comprising telmisartan and hydrochlorothiazide |
| 08/31/2011 | EP1460060B2 Method of obtaining novel lutein-based formulations |
| 08/31/2011 | EP1443938B1 Dosage unit comprising a prostaglandin analog for treating constipation |
| 08/31/2011 | EP1401498B1 Anti-ngf antibodies for the treatment of various disorders |
| 08/31/2011 | EP1361869B1 Transdermal therapeutic system containing testosterone and method for the production thereof |
| 08/31/2011 | EP1339394B1 Pharmaceutical preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 08/31/2011 | EP1320362B1 Stabilised fibrate microparticles |
| 08/31/2011 | EP1209149B9 Substituted aromatic-ring compounds, process for producing the same, and use |
| 08/31/2011 | EP1109562B1 Composite biocidal particles |
| 08/31/2011 | EP1079824B1 Triterpene compositions and methods for use thereof |
| 08/31/2011 | CN201947851U 一种蜜蜂专用杀蜂螨药片 Dedicated bee bee mites kill pill |
| 08/31/2011 | CN1990478B 6-aryl-3-substituted methylene pyranone compounds, preparation process and use thereof |
| 08/31/2011 | CN1989972B Finasteroid oral preparation and method for preparing same |
| 08/31/2011 | CN1985846B Use of brown algae polyose sulfate in preparing medicine for treating cardic and cerebral vascular diseases |
| 08/31/2011 | CN1976679B Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 08/31/2011 | CN1946726B Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 08/31/2011 | CN1946387B Use of 4-hydroxy tamoxifen in treatment and prevention of benign breast disease |
| 08/31/2011 | CN1939920B Eastern poppy base compound and its medical use |
| 08/31/2011 | CN1918119B Bicycloester derivative |
| 08/31/2011 | CN1914194B Therapeutic agent for vasospasm accompanying bypass operation |
| 08/31/2011 | CN1913875B Anionic hydrogel matrices with pH dependent modified release as drug carriers |
| 08/31/2011 | CN1895242B Diclofenac salt pleximetric paste and its production |
| 08/31/2011 | CN1863798B 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 08/31/2011 | CN1861604B Crystal form of asenapine maleate |
| 08/31/2011 | CN1835922B Process for preparation of 4-aryl-nicotinamide derivatives |
| 08/31/2011 | CN1830448B Aldfuwei ester injection having liver target and its preparation method |
| 08/31/2011 | CN1813683B Azithromycin for suspension and its preparing method |
| 08/31/2011 | CN1744896B Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist |
| 08/31/2011 | CN1659162B Tricyclic thrombin receptor antagonists |
| 08/31/2011 | CN1433314B Antimicrobial compositions and methods of use |
| 08/31/2011 | CN102171342A Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means |
| 08/31/2011 | CN102171235A Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 08/31/2011 | CN102171234A Photo-crosslinked nucleic acid hydrogels |
| 08/31/2011 | CN102171233A Process for preparing azacytidine intermediate |
| 08/31/2011 | CN102171221A Novel fused aminodihydrothiazine derivative |
| 08/31/2011 | CN102171220A Pyrazolo [5, 1-b] oxazole derivatives as CRF1 antagonists |
| 08/31/2011 | CN102171219A Crystalline forms of a pyridine derivative |
| 08/31/2011 | CN102171218A Indole derivatives suitable for imaging neuroinflammation |
| 08/31/2011 | CN102171214A Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 08/31/2011 | CN102171213A Pyrazolo [3, 4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity |
| 08/31/2011 | CN102171211A Piperidine derivatives as JAK3 inhibitors |
| 08/31/2011 | CN102171210A Imidazopyridin-2-on derivative |